Annette P N Kutter

Dr. Annette P N Kutter

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Biomaterials
Verified
Journal Article
Closed access
FTFelix Theiss
Felix Theiss
DADetlef Apelt
Detlef Apelt
BBBastian Brand
Bastian Brand
AKAnnette P N Kutter
Annette P N Kutter
KZKatalin Zlinszky
Katalin Zlinszky
BRBrigitte von Rechenberg
Brigitte von Rechenberg

1 April 2003 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
BRB von Rechenberg
B von Rechenberg
MAM.K Akens
M.K Akens
DND Nadler
D Nadler
PBP Bittmann
P Bittmann
KZK Zlinszky
K Zlinszky
JAJ.A Auer
J.A Auer

1 July 2017 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
NSNadja Sigrist
Nadja Sigrist
NHN. Hofer-Inteeworn
N. Hofer-Inteeworn
RSR. Jud Schefer
R. Jud Schefer
CKC. Kuemmerle-Fraune
C. Kuemmerle-Fraune
Manuela SchnyderManuela Schnyder
Manuela Schnyder
AKAnnette P N Kutter
Annette P N Kutter
The pathomechanism of Angiostrongylus vasorum infection-associated bleeding diathesis in dogs is not fully understood. To describe rotational thromboelastometry (ROTEM) parameters in dogs naturally infected with A. vasorum and to compare ROTEM parameters between infected dogs with and without clinical signs of bleeding. A total of 21 dogs presented between 2013 and 2016. Dogs with A. vasorum infection and ROTEM evaluation were retrospectively identified. Thrombocyte counts, ROTEM parameters, clinical signs of bleeding, therapy, and survival to discharge were retrospectively retrieved from patient records and compared between dogs with and without clinical signs of bleeding. Evaluation by ROTEM showed hyperfibrinolysis in 8 of 12 (67%; 95% CI, 40–86%) dogs with and 1 of 9 (11%; 95% CI, 2–44%) dogs without clinical signs of bleeding (P = .016). Hyperfibrinolysis was associated with severe hypofibrinogenemia in 6 of 10 (60%; 95% CI, 31–83%) of the cases. Hyperfibrinolysis decreased or resolved after treatment with 10–80 mg/kg tranexamic acid. Fresh frozen plasma (range, 14–60 mL/kg) normalized follow-up fibrinogen function ROTEM (FIBTEM) maximal clot firmness in 6 of 8 dogs (75%; 95% CI, 41–93%). Survival to discharge was 67% (14/21 dogs; 95% CI, 46–83%) and was not different between dogs with and without clinical signs of bleeding (P = .379). Hyperfibrinolysis and hypofibrinogenemia were identified as an important pathomechanism in angiostrongylosis-associated bleeding in dogs. Hyperfibrinolysis and hypofibrinogenemia were normalized by treatment with tranexamic acid and plasma transfusions, respectively.

4 November 2006 in Veterinary Record
Verified
Journal Article
Closed access
PDF file
AKAnnette P N Kutter
Annette P N Kutter
SKS. B. R. Kästner
S. B. R. Kästner
RBRegula Bettschart-Wolfensberger
Regula Bettschart-Wolfensberger
MHM. Huhtinen
M. Huhtinen
In sheep, α 2 ‐agonists can induce severe hypoxaemia. In goats, reports on changes in oxygenation are inconsistent. The aim of this study was to compare the cardiopulmonary effects of dexmedetomidine in six goats and four sheep anaesthetised with sevoflurane and maintained at approximately 1 minimal alveolar concentration. The animals were ventilated mechanically and held in an upright position to minimise the influence of positioning on pulmonary function. After baseline cardiopulmonary measures, 2 μg/kg dexmedetomidine was injected intravenously over one minute, and measurements were made for 120 minutes. In both species, respiratory resistance, alveolar dead space and shunt fraction increased and thoracic compliance decreased significantly; arterial, pulmonary arterial, pulmonary capillary wedge and central venous pressures increased and heart rate and cardiac output decreased significantly. Arterial oxygen tension decreased significantly, with no significant difference between the goats and sheep. Wide interindividual differences were observed in both the goats (mean [sd] 144 [149·1] mmHg, range 54·8 to 443·7 mmHg) and sheep (mean [sd] 129·8 [132·1] mmHg, range 33·7 to 352·8 mmHg), but the cardiovascular and respiratory changes were similar in the two species.

1 September 2005 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
SKSabine B. R. Kästner
Sabine B. R. Kästner
SKSusanne Kull
Susanne Kull
AKAnnette P N Kutter
Annette P N Kutter
JBJolanda Boller
Jolanda Boller
RBRegula Bettschart-Wolfensberger
Regula Bettschart-Wolfensberger
MHMirja K. Huhtinen
Mirja K. Huhtinen
Objective—To determine whether inhaled nitric oxide (NO) prevents pulmonary hypertension and improves oxygenation after IV administration of a bolus of dexmedetomidine in anesthetized sheep. Animals—6 healthy adult sheep. Procedure—In a crossover study, sevoflurane-anesthetized sheep received dexmedetomidine (2 µg/kg, IV) without NO (DEX treatment) or with inhaled NO (DEX-NO treatment). Cardiopulmonary variables, including respiratory mechanics, were measured before and for 120 minutes after bolus injection of dexmedetomidine. Results—Dexmedetomidine induced a transient decrease in heart rate and cardiac output. A short-lived increase in mean arterial pressure (MAP) and systemic vascular resistance (SVR) was followed by a significant decrease in MAP and SVR for 90 minutes. Mean pulmonary arterial pressure (MPAP) and pulmonary vascular resistance increased transiently after dexmedetomidine injection. The PaO2 was significantly decreased 3 minutes after injection and reached a minimum of (mean ± SEM) 13.3 ± 7.8 kPa 10 minutes after injection. The decrease in PaO2 was accompanied by a sudden and prolonged decrease in dynamic compliance and a significant increase in airway resistance, shunt fraction, and alveolar dead space. Peak changes in MPAP did not differ between the 2 treatments. For the DEX-NO treatment, PaO2 was significantly lower and the shunt fraction significantly higher than for the DEX treatment. Conclusions and Clinical Relevance—Inhalation of NO did not prevent increases in pulmonary arterial pressures induced by IV administration of dexmedetomidine. Preemptive inhalation of NO intensified oxygenation impairment, probably through increases in intrapulmonary shunting. (Am J Vet Res 2005;66:1496–1502)

1 May 2003 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
TGTony M. Glaus
Tony M. Glaus
MMMike Martin
Mike Martin
MBManuel Boller
Manuel Boller
MJMike Stafford Johnson
Mike Stafford Johnson
AKAnnette P N Kutter
Annette P N Kutter
MTMagdi Tofeig
Magdi Tofeig